Company intelligence / Profile preview

LTT Bio-Pharma Co., Ltd.

Tokyo, Tokyo-to, Japanltt.co.jp ↗

Ownership: Private
Employees: ~32
Development stage: Commercial

Overview

LTT Bio-Pharma has advanced several programs to Phase II clinical trials. Notably:

LT‑4002 and LT‑0303 diclofenac sodium eye-drops have completed randomized double-blind placebo-controlled Phase II studies in dry eye syndrome patients.
Other pipeline assets are at the Phase II stage targeting nerve degeneration, dyspepsia, hematologic neoplasms, COPD, and irritable bowel syndrome. The company leverages proprietary drug delivery technologies and a strong focus on drug repositioning.

Therapeutic areas: PulmonologyHematologyGastroenterologyOphthalmologyNeurology
Modalities: Small moleculesEnzymesMonoclonal antibodies
Industry: Biotech

Drug pipeline

12 assets

lecithinized superoxide dismutase

11 more assets in the full pipeline.

Request access →

Partnerships

Collaborations with academic institutions such as Nihon University and Shujitsu University for contract researchPartnerships with pharmaceutical companies via joint development projects focused on DDS technology transfer from academia to industry

Beyond the preview

Go deeper on LTT Bio-Pharma Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LTT Bio-Pharma Co., Ltd..

Explore the full profile